15 results
PATH
Current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea in all settings, but they are not as effective in places with the highest burden. Alternative approaches in advanced...
Verónica Carrión, Silas P.Trumbo, Renee Aquije, Misael Gómez, Martha Velandia-González, Marcela Contreras, M. Carolina Danovaro-Holliday, Karim Jaqueline Pardo Ruiz, Fabio Alberto Escobar Díaz, Ana Gabriela Félix García
Introduction The Global Vaccine Action Plan and the Regional Immunization Action Plan of the Americas call for countries to improve immunization data quality. Immunization information systems,...
Victor Suarez et al.
Abstract Streptococcus pneumoniae is the leading cause of bacterial pneumonia, meningitis and sepsis in children worldwide. Despite available evidence on pneumococcal conjugate vaccine (PCV) impact...
Martí SG et al.
BACKGROUND: A recently developed 10-valent pneumococcal non-typeable H influenzae protein D-conjugate vaccine (PHiD-CV) is expected to afford protection against more than two thirds of isolates...
Theresa J. Ochoa et al.
There is little information about vaccine schedule compliance in very-low-birth-weight infants in developing countries. The aim of the study was to describe the compliance with the vaccine schedule...
Sánchez Anabella et al.
In 2015, Peru’s Ministry of Health (MOH), in partnership with the USAID | DELIVER PROJECT, implemented and co-funded a costing study for warehousing and transportation in La Libertad Region. The...
Rishi Desai et al.
With the recent postlicensure identification of an increased risk of intussusception with rotavirus vaccine, the 14 Latin American countries currently using rotavirus vaccine must now weigh the...
Rifat Atun et al.
Starting in the late 1980s, many Latin American countries began social sector reforms to alleviate poverty, reduce socioeconomic inequalities, improve health outcomes, and provide financial risk...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
Ángela MaríaRuiz-Sternberg
Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine....
Adriana Guzmán-Holst, Thatiana de Jesus Pereira Pinto, Ingrid Leal, María M. Castrejon
Globally, an estimated 23 million children missed vaccination in 2020 due to the coronavirus disease 2019 (COVID-19) pandemic. This article analyzes vaccination coverage trends and catch-up...
Iván Arroyave, Lucero Sangster-Carrasco, Carolina Mendez-Guerra, Claudia Silva-Perez, Ali Al-Kassab-Córdova
This study aims at identifying the associated factors and assessing the inequalities of full vaccination coverage (FVC) among Peruvian infants aged 12-23 months during the COVID-19 pandemic in a...